Searched for
DR LAL PATHLABS Q3 EARNINGS
Trump makes over 3,700 trades in Q1; Nvidia, Intel, Microsoft, Netflix part of portfolio20 May, 2026, 04.37 PM IST- Bharath Uppiliappan on Q2 revenue drivers for Dr Lal PathLabs09 Nov, 2020, 10.32 PM IST
- Reliance Industries Q4 Results: Profit falls 13% YoY as energy margins weaken; Jio and retail shine24 Apr, 2026, 09.20 PM IST
- Stock Radar: Breakout with high volumes in Dr Lal PathLabs could lead to a trending phase in the near term, says Ruchit Jain05 Oct, 2023, 07.00 AM IST
- Tech Mahindra Press Conference | Q4 FY26 Results | Management Briefing | LIVE22 Apr, 2026, 05.27 PM IST
- Alkem, Pathlabs soar in stellar debut on bourses23 Dec, 2015, 12.37 PM IST
- IIFL on Alkem Labs and Dr Lal Pathlabs IPO08 Dec, 2015, 02.33 PM IST
- Dr Reddy's Q3 Results: Profit meets estimates, jumps 11% YoY to Rs 1,379 cr; revenue up 7%30 Jan, 2024, 05.36 PM IST
- Seen 21% growth in revenue in FY16: Dr Lal Pathlabs03 Mar, 2016, 12.01 PM IST
- Watch: Dr Reddy's Labs Q3 consol PAT at Rs 334 crore25 Jan, 2018, 02.49 PM IST
- Stocks in news: Idea Cellular, GVK Power and Dr Lal Pathlab25 Oct, 2017, 08.20 AM IST
- Stocks in news: Idea Cellular, GVK Power and Dr Lal Pathlab25 Oct, 2017, 08.25 AM IST
- HCL Tech To Infosys: Key Q3 Earnings In Focus This Week13 Jan, 2025, 09.00 AM IST
- LIVE | Wipro Q4 results: Profit drops 1.89% on yearly basis | Earnings under pressure16 Apr, 2026, 05.27 PM IST
- HCL Tech Q4 Results: PAT up 4% YoY at Rs 4,488 cr; Rs 24 per share dividend declared21 Apr, 2026, 08.08 PM IST
- Wipro Q3 Results: PAT jumps 24% YoY to Rs 3,354 crore; ₹6 dividend declared17 Jan, 2025, 04.26 PM IST
- Dr Reddy's Laboratories misses estimates in Q309 Feb, 2016, 02.27 PM IST
- Tech Mahindra Q3 Results: Profit soars by 93%; revenue grows 1.4% year-on-year17 Jan, 2025, 05.10 PM IST
- Wipro results: Q3 net up 10 per cent; IT chiefs quitET8.jpg21 Jan, 2011, 11.13 AM IST
- TCS Q3 Results: Profit rises 2% YoY to Rs 11,058 cr; board approves dividend of Rs 27/share11 Jan, 2024, 04.25 PM IST
Load More
